Compound details
D-2-Hydroxyglutaric acid
| Compound ID | CDAMM02314 |
|---|---|
| Common name | D-2-Hydroxyglutaric acid | IUPAC name | 2-hydroxypentanedioic acid |
| Molecular formula | C5H8O5 |
| Retention time | 14.46 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 149.044 | Theoretical mz | 149.044 |
| Error | 3.19 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.8112 |
| Inchi key | HWXBTNAVRSUOJR-YEQUQEJONA-N |
|---|---|
| Smiles | O=C(O)CCC(O)C(=O)O |
| Superclass | Organic acids and derivatives |
| Class | Hydroxy acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| P48066 | SLC6A11 | GABA transporter 3 | T38200 | SEA |
| O75899 | GABBR2 | GABA-B receptor | T42446 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| P78352 | DLG4 | Disks large homolog 4 | T04507 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| Q07075 | ENPEP | Aminopeptidase A | T31956 | SEA |
| P41229 | KDM5C | Lysine-specific demethylase 5C | T85540 | SEA |
| Q9Y2K7 | KDM2A | Lysine-specific demethylase 2A | T71949 | SEA |
| Q9Y3Q0 | NAALAD2 | NAALADase II | T70036 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| P53396 | ACLY | ATP-citrate synthase | T52189 | SwissTargetPrediction |
| Q9UPP1 | PHF8 | Histone lysine demethylase PHF8 | T00933 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q4U2R8 | SLC22A6 | Solute carrier family 22 member 6 (by homology) | T70680 | SEA |
| Q9UN88 | GABRQ | GABA(A) receptor theta | T15161 | SEA |
| O60603 | TLR2 | Toll-like receptor 2 | T82078 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T38200 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P48066 | SLC6A11 |
| T42446 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O75899 | GABBR2 |
| T42446 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | O75899 | GABBR2 |
| T42446 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | O75899 | GABBR2 |
| T42446 | DI0290 | Narcolepsy | [ICD-11: 7A20] | O75899 | GABBR2 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T04507 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P78352 | DLG4 |
| T04507 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P78352 | DLG4 |
| T31956 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | Q07075 | ENPEP |
| T52189 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P53396 | ACLY |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T70680 | DI0167 | Gout | [ICD-11: FA25] | Q4U2R8 | SLC22A6 |
| T70680 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q4U2R8 | SLC22A6 |
| T70680 | DI0310 | Ocular disease | [ICD-11: N.A.] | Q4U2R8 | SLC22A6 |
| T82078 | DI0346 | Prostate cancer | [ICD-11: 2C82] | O60603 | TLR2 |